Age-Related Macular Degeneration (AMD)

FDA Rules Against For-Profit Stem Cell Company

Quick on the heels of last week’s Washington Post article discussing the dangers of stem cell therapy, a U.S. federal judge ruled in favour of the Food and Drug Administration (FDA) in…

Restoring Vision with Stem Cells

Dr. David Gamm is a pediatric ophthalmologist investigating how stem cells can be used as a potential treatment for retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Dr. Gamm’s research is supported…

Trusting Stem Cell Therapies

Recently, an article published by the Washington Post discussed the growing number of stem cell clinics in the United States offering “cures” for conditions like age-related macular degeneration, multiple sclerosis, and Parkinson’s…

Fighting Blindness Canada Calls for Safety Study Regarding the Use of Off-Label Injections to Treat Blinding Eye Diseases in British Columbia

In light of a recent article published by the Globe and Mail regarding the potential correlation between Avastin injections and increased glaucoma rates specifically in British Columbia, Fighting Blindness Canada is republishing…

FROM FOUNDATION TO FIGHTER

A LETTER FROM THE PRESIDENT AND CEO For 45 years, the Foundation Fighting Blindness has raised and directed critical funding into sight-saving research for blinding eye diseases. From our earliest days as…

Together We Will Cure Blindness

Right now, over one million Canadians are living with blinding eye diseases and as vision fades, so too can hope. To date, donors of the Fighting Blindness Canada (FBC) have contributed more…

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.